EXICURE, INC.

XCUR · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 8 employees
227
SEC Filings
$3.33
Close 2026-06-01
8
Employees

Business Summary

. Overview Historically, we have been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, we announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that we were exploring strategic alternatives to maximize stockholder value. In February 2024, we received an upfront payment of $500,000 from a licensing agreement for paten...

Latest Stock Quote

XCUR 2026-06-01 $3.33 O:$3.285 H:$3.33 L:$2.99 Vol:0.0M VWAP:$3.1525
origin leaf: 950c0b0ffd259c7f5ff44c5d16c0b5e899f5609827afd1cc7d93ba86ad178f02

Next Earnings

Q2 FY2026 — expected 2026-09-06

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001698530-26-000028EDGAR44K words
2025-03-182024-12-310001698530-25-000019EDGAR—
2024-06-062023-12-310001698530-24-000051EDGAR—
2023-03-272022-12-310001698530-23-000029EDGAR—
2022-03-252021-12-310001698530-22-000019EDGAR—
2021-03-112020-12-310001698530-21-000031EDGAR—
2020-03-102019-12-310001698530-20-000013EDGAR—
2019-03-082018-12-310001698530-19-000015EDGAR—
2018-03-092017-12-310001698530-18-000007EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001698530-25-000100EDGAR18K words
2025-08-082025-06-300001698530-25-000077EDGAR—
2025-06-272025-03-310001698530-25-000056EDGAR—
2024-11-142024-09-300001698530-24-000117EDGAR—
2024-08-132024-06-300001698530-24-000089EDGAR—
2024-06-172024-03-310001698530-24-000068EDGAR—
2024-05-162023-09-300001698530-24-000030EDGAR—
2023-08-112023-06-300001698530-23-000091EDGAR—
2023-07-142023-03-310001698530-23-000079EDGAR—
2022-11-142022-09-300001698530-22-000088EDGAR—
2022-08-152022-06-300001698530-22-000058EDGAR—
2022-05-162022-03-310001698530-22-000033EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001698530-26-000034EDGAR14K words
2026-03-270001698530-26-000031EDGAR—
2026-03-250001698530-26-000026EDGAR—
2026-02-170001698530-26-000013EDGAR—
2026-02-100001698530-26-000009EDGAR—
2026-01-220001698530-26-000007EDGAR—
2025-11-170001698530-25-000105EDGAR—
2025-11-100001698530-25-000102EDGAR—
2025-11-070001698530-25-000099EDGAR—
2025-09-090001698530-25-000081EDGAR—

227 total filings indexed. 196 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001698530
TickerXCUR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.exicuretx.com
Listed2018-05-09

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4a23c7bfed490f93bf031fe5f5e7eca35de4fc607e534b4ea3509bcbf81ebd01
parent: ace0f9f45ead2de24641c359f7accdc1420a1af0571bfc344d0cd4a8d275401e
content hash: 52757296490180bca51a66ba26e70ad2c1a15c1faa747c0060a1a718c7756d8d
signed: 2026-06-03T12:03:06.322Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf